Your browser doesn't support javascript.
loading
Remdesivir-ivermectin combination displays synergistic interaction with improved in vitro activity against SARS-CoV-2.
Jeffreys, Laura N; Pennington, Shaun H; Duggan, Jack; Caygill, Claire H; Lopeman, Rose C; Breen, Alastair F; Jinks, Jessica B; Ardrey, Alison; Donnellan, Samantha; Patterson, Edward I; Hughes, Grant L; Hong, David W; O'Neill, Paul M; Aljayyoussi, Ghaith; Owen, Andrew; Ward, Stephen A; Biagini, Giancarlo A.
Afiliação
  • Jeffreys LN; Centre for Drugs and Diagnostics, Department of Tropical Disease Biology, Liverpool School of Tropical Medicine, Liverpool, UK.
  • Pennington SH; Centre for Drugs and Diagnostics, Department of Tropical Disease Biology, Liverpool School of Tropical Medicine, Liverpool, UK. Electronic address: shaun.pennington@lstmed.ac.uk.
  • Duggan J; Centre for Drugs and Diagnostics, Department of Tropical Disease Biology, Liverpool School of Tropical Medicine, Liverpool, UK.
  • Caygill CH; Centre for Drugs and Diagnostics, Department of Tropical Disease Biology, Liverpool School of Tropical Medicine, Liverpool, UK.
  • Lopeman RC; Centre for Drugs and Diagnostics, Department of Tropical Disease Biology, Liverpool School of Tropical Medicine, Liverpool, UK.
  • Breen AF; Centre for Drugs and Diagnostics, Department of Tropical Disease Biology, Liverpool School of Tropical Medicine, Liverpool, UK.
  • Jinks JB; Centre for Drugs and Diagnostics, Department of Tropical Disease Biology, Liverpool School of Tropical Medicine, Liverpool, UK.
  • Ardrey A; Centre for Drugs and Diagnostics, Department of Tropical Disease Biology, Liverpool School of Tropical Medicine, Liverpool, UK.
  • Donnellan S; Centre for Drugs and Diagnostics, Department of Tropical Disease Biology, Liverpool School of Tropical Medicine, Liverpool, UK.
  • Patterson EI; Centre for Drugs and Diagnostics, Department of Tropical Disease Biology, Liverpool School of Tropical Medicine, Liverpool, UK; Department of Vector Biology, Liverpool School of Tropical Medicine, Liverpool, UK.
  • Hughes GL; Centre for Drugs and Diagnostics, Department of Tropical Disease Biology, Liverpool School of Tropical Medicine, Liverpool, UK; Department of Vector Biology, Liverpool School of Tropical Medicine, Liverpool, UK.
  • Hong DW; Department of Chemistry, University of Liverpool, Liverpool, UK.
  • O'Neill PM; Department of Chemistry, University of Liverpool, Liverpool, UK.
  • Aljayyoussi G; Centre for Drugs and Diagnostics, Department of Tropical Disease Biology, Liverpool School of Tropical Medicine, Liverpool, UK.
  • Owen A; Department of Pharmacology and Therapeutics, Centre of Excellence in Long-acting Therapeutics, University of Liverpool, Liverpool, UK.
  • Ward SA; Centre for Drugs and Diagnostics, Department of Tropical Disease Biology, Liverpool School of Tropical Medicine, Liverpool, UK.
  • Biagini GA; Centre for Drugs and Diagnostics, Department of Tropical Disease Biology, Liverpool School of Tropical Medicine, Liverpool, UK. Electronic address: giancarlo.biagini@lstmed.ac.uk.
Int J Antimicrob Agents ; 59(3): 106542, 2022 Mar.
Article em En | MEDLINE | ID: mdl-35093538
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / Tratamento Farmacológico da COVID-19 Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / Tratamento Farmacológico da COVID-19 Idioma: En Ano de publicação: 2022 Tipo de documento: Article